Four modules to steer AI in a pharmaceutical company, from assessment to monitoring
AI Compass brings together four complementary modules, designed for pharmaceutical, biotech and medtech companies. Each one answers a question: where do we stand, are we compliant, what comes first, and how do we keep track over time.
Inventory: know where you stand, and where the industry stands
Inventory maps your AI tools and benchmarks your maturity against the pharmaceutical industry. Your leadership team decides on AI investments with hard reference points: what the most advanced companies do, what you lack, where to start.

Diagnostic: assess the compliance of each tool in 15 minutes
Diagnostic assesses each AI tool and use case against the EU AI Act, the EMA reflection paper on AI, ICH Q9 (R1), GxP, MDR/IVDR and GDPR. It is where most companies start: the first assessment is free.

Roadmap: from assessment to action plan
A recommendation only helps once it is part of your quality system. Roadmap turns the assessment into a compliance plan: actions ranked by priority, with owners and deadlines.

Regulations: track compliance and ROI continuously
Regulations tracks over time what the other three modules set up: the deployment of AI tools, their compliance, their performance and their ROI. AI compliance is then managed like pharmacovigilance: continuously, with alerts.
